These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 39178114)

  • 1. The TRIM4 E3 ubiquitin ligase degrades TPL2 and is modulated by oncogenic KRAS.
    Bansod S; Dodhiawala PB; Geng Y; Bulle A; Liu P; Li L; Townsend R; Grierson PM; Held JM; Adhikari H; Lim KH
    Cell Rep; 2024 Sep; 43(9):114667. PubMed ID: 39178114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations.
    Dodhiawala PB; Khurana N; Zhang D; Cheng Y; Li L; Wei Q; Seehra K; Jiang H; Grierson PM; Wang-Gillam A; Lim KH
    J Clin Invest; 2020 Sep; 130(9):4771-4790. PubMed ID: 32573499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of artesunate and WNT974 induces KRAS protein degradation by upregulating E3 ligase ANACP2 and β-TrCP in the ubiquitin-proteasome pathway.
    Gong RH; Chen M; Huang C; Wong HLX; Kwan HY; Bian Z
    Cell Commun Signal; 2022 Mar; 20(1):34. PubMed ID: 35305671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Catenin-RAS interaction serves as a molecular switch for RAS degradation via GSK3β.
    Lee SK; Jeong WJ; Cho YH; Cha PH; Yoon JS; Ro EJ; Choi S; Oh JM; Heo Y; Kim H; Min DS; Han G; Lee W; Choi KY
    EMBO Rep; 2018 Dec; 19(12):. PubMed ID: 30413483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Gsk3β-β-TrCP interaction is required for late phase stabilization of β-catenin in canonical Wnt signaling.
    Gao C; Chen G; Romero G; Moschos S; Xu X; Hu J
    J Biol Chem; 2014 Mar; 289(10):7099-7108. PubMed ID: 24451375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximab.
    Lee SK; Cho YH; Cha PH; Yoon JS; Ro EJ; Jeong WJ; Park J; Kim H; Il Kim T; Min DS; Han G; Choi KY
    Exp Mol Med; 2018 Nov; 50(11):1-12. PubMed ID: 30459318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted degradation of KRAS by an engineered ubiquitin ligase suppresses pancreatic cancer cell growth in vitro and in vivo.
    Ma Y; Gu Y; Zhang Q; Han Y; Yu S; Lu Z; Chen J
    Mol Cancer Ther; 2013 Mar; 12(3):286-94. PubMed ID: 23288781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRAS protein stability is regulated through SMURF2: UBCH5 complex-mediated β-TrCP1 degradation.
    Shukla S; Allam US; Ahsan A; Chen G; Krishnamurthy PM; Marsh K; Rumschlag M; Shankar S; Whitehead C; Schipper M; Basrur V; Southworth DR; Chinnaiyan AM; Rehemtulla A; Beer DG; Lawrence TS; Nyati MK; Ray D
    Neoplasia; 2014 Feb; 16(2):115-28. PubMed ID: 24709419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ubiquitin ligase RNF220 enhances canonical Wnt signaling through USP7-mediated deubiquitination of β-catenin.
    Ma P; Yang X; Kong Q; Li C; Yang S; Li Y; Mao B
    Mol Cell Biol; 2014 Dec; 34(23):4355-66. PubMed ID: 25266658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Transcription Factor SP1 by the β-Catenin Destruction Complex Modulates Wnt Response.
    Mir R; Sharma A; Pradhan SJ; Galande S
    Mol Cell Biol; 2018 Nov; 38(22):. PubMed ID: 30181396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM21 induces selective autophagic degradation of c-Myc and sensitizes regorafenib therapy in colorectal cancer.
    Ye WL; Huang L; Yang XQ; Wan S; Gan WJ; Yang Y; He XS; Liu F; Guo X; Liu YX; Hu G; Li XM; Shi WY; He K; Wu YY; Wu WX; Lu JH; Song Y; Qu CJ; Wu H
    Proc Natl Acad Sci U S A; 2024 Oct; 121(42):e2406936121. PubMed ID: 39388269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of Tumor Suppressive Function of FBXO16 Ubiquitin Ligase Activates Wnt Signaling In Glioblastoma.
    Khan M; Muzumdar D; Shiras A
    Neoplasia; 2019 Jan; 21(1):106-116. PubMed ID: 30530053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HECT (Homologous to the E6-AP Carboxyl Terminus)-Type Ubiquitin E3 Ligase ITCH Attenuates Cardiac Hypertrophy by Suppressing the Wnt/β-Catenin Signaling Pathway.
    Goto J; Otaki Y; Watanabe T; Kobayashi Y; Aono T; Watanabe K; Wanezaki M; Kutsuzawa D; Kato S; Tamura H; Nishiyama S; Arimoto T; Takahashi H; Shishido T; Watanabe M
    Hypertension; 2020 Dec; 76(6):1868-1878. PubMed ID: 33131309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCF
    Suber T; Wei J; Jacko AM; Nikolli I; Zhao Y; Zhao J; Mallampalli RK
    J Biol Chem; 2017 May; 292(18):7452-7461. PubMed ID: 28298444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SIAH E3 ubiquitin ligases promote Wnt/β-catenin signaling through mediating Wnt-induced Axin degradation.
    Ji L; Jiang B; Jiang X; Charlat O; Chen A; Mickanin C; Bauer A; Xu W; Yan X; Cong F
    Genes Dev; 2017 May; 31(9):904-915. PubMed ID: 28546513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EDD E3 ubiquitin ligase ubiquitinates and up-regulates beta-catenin.
    Hay-Koren A; Caspi M; Zilberberg A; Rosin-Arbesfeld R
    Mol Biol Cell; 2011 Feb; 22(3):399-411. PubMed ID: 21118991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel GSK3β inhibitor involved in abrogating KRas dependent pancreatic tumors in Wnt/beta-catenin and NF-kB dependent manner.
    Ayaz MO; Bhat AQ; Akhter Z; Badsera N; Hossain MM; Showket F; Parveen S; Dar MS; Tiwari H; Kumari N; Bhardwaj M; Hussain R; Sharma A; Kumar M; Singh U; Nargorta A; Kshatri AS; Nandi U; Monga SP; Ramajayan P; Singh PP; Dar MJ
    Life Sci; 2024 Aug; 351():122840. PubMed ID: 38876185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer.
    Ji S; Qin Y; Shi S; Liu X; Hu H; Zhou H; Gao J; Zhang B; Xu W; Liu J; Liang D; Liu L; Liu C; Long J; Zhou H; Chiao PJ; Xu J; Ni Q; Gao D; Yu X
    Cell Res; 2015 May; 25(5):561-73. PubMed ID: 25753158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The E3 Ligase TRIM4 Facilitates SET Ubiquitin-Mediated Degradation to Enhance ER-α Action in Breast Cancer.
    Han D; Wang L; Long L; Su P; Luo D; Zhang H; Li Z; Chen B; Zhao W; Zhang N; Wang X; Liang Y; Li Y; Hu G; Yang Q
    Adv Sci (Weinh); 2022 Sep; 9(25):e2201701. PubMed ID: 35843886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A MET-PTPRK kinase-phosphatase rheostat controls ZNRF3 and Wnt signaling.
    Kim M; Reinhard C; Niehrs C
    Elife; 2021 Sep; 10():. PubMed ID: 34590584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.